Abstract:OBJECTIVE To explore the preventive and therapeutic effects of simvastatin on rats with chronic obstructive pulmonary disease (COPD) and examine the mechanism of airway inflammation and airway mucus hypersecretion. METHODS The rat model of COPD was established by cigarette smoking and an intratracheal injection of lipopolysaccharide (LPS). A total of 18 male Sprague-Dawley rats were randomly divided into control, COPD and simvastatin groups (n=6 each). The control and COPD groups received normal saline once daily via intragastric administration (i.g.) while the simvastatin group had simvastatin (0.5 g/L) 1 ml/100 g once daily via i.g. Pulmonary function was tested and pathological changes in bronchus and lung were observed. The bronchoalveolar lavage fluid (BALF) levels of interleukin-8 (IL-8), interleukin-17 (IL-17) and tumor necrosis factor (TNF)-α were measured by enzyme-linked immunosorbent assay (ELISA). The protein expressions of intercellular adhesion molecule 1 (ICAM-1), nuclear factor κB (NF-κB), mucin 5AC (MUC5AC) and Toll-like receptor 4 (TLR4) in rat airway were detected by immunohistochemical staining. The mRNA and protein expressions of TLR4 and MUC5AC in bronchi and lung tissue were detected by fluorescent real time quantitative polymerase chain reaction (RT-PCR) and Western blot. RESULTS The changes of bronchi and lung tissues in COPD group were consistent with typical pathological manifestations of COPD. As compared with the COPD group, the degree of pulmonary pathological damage and the decline of pulmonary function in the simvastatin group were significantly lessened, but still remarkable as compared with the control group. The BALF levels of IL-8, IL-17 and TNF-α in the smvastatin group [(484.4 ± 11.1), (78.9 ± 2.0), (192.7 ± 2.0) ng/L] were significantly lower than those in the COPD group [(605 ± 48.7), (89.9 ± 6.9), (212.6 ± 10.7) ng/L], but still higher than those in the control group [(341.2 ± 21.4), (56.0 ± 2.9), (127.5 ± 9.0) ng/L respectively] (all P <0.01). Compared with COPD group, the expression levels of ICAM-1, NF-κB, MUC5AC and TLR4 protein were significantly lower in the simvastatin group, but still higher than the control group (all P <0.01). Furthermore, the expression levels of mRNA and protein of MUC5AC and TLR4 were significantly lower in the simvastatin group than those in the COPD group (all P <0.05). CONCLUSIONS In COPD model rats, simvastatin can decrease the levels of IL-8, IL-17 and TNF-α in BALF and inhibit the expression levels of ICAM-1, NF-κB, MUC5AC and TLR4 protein in airway and lung tissue. Thus it plays preventive and therapeutic roles by reducing airway inflammation and airway mucus hypersecretion.

Beneficial Effect of Simvastatin on Pancreatic Islet Insulin Secretion and ROS Damage in Diabetic Rats

Protective effects and the mechanism of Rosuvastatin on type 2 diabetic rats

The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats

Effects of Simvastatin on Cardiac Performance and Expression of Sarco-Plasmic Reticular Calcium Regulatory Proteins in Rat Heart

Effects of simvastatin on cardiohemodynamic responses to ischemia–reperfusion in isolated rat hearts

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1

THE MYOCARDIAL PROTECTIVE EFFECTS OF PUERARIN ON STZ-INDUCED DIABETIC RATS

The Effect of Simvastatin on the Renal Protection and the Urinary VEGF Excretion in Diabetic Rats

Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha

The Effect of Simvastatin on the Urinary Protein Excretion of Diabetic Rats

Effect of Rosiglitazone on the Function and Morphology of Pancreatic Beta-Cell in Type 2 Diabetic Rats

Effect of Simvastatin on the Renal Injury of Diabetic Rats and Excretion of Urine TGF-β1

[Research on the Effect of Statins on Insulin Secretion from Pancreatic Islet in Rats and Its Mechanisms].

The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet

[The Effect of High Fat Feeding and Rosiglitazone Intervention on Pancreatic Alpha Cell in Rats].

Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression

Insulin Therapy Improves Islet Functions by Restoring Pancreatic Vasculature in High-Fat Diet-Fed Streptozotocin-Diabetic Rats

Effects of Simvastatin on Oxidative Stress of Myocardium and Ventricular Remodeling in Postinfarction Heart Failure Rats

The Effects of Simvastatin Therapy on Endothelial Function and Inflammatory Factor in Type 2 Diabetes Mellitus Without Cardiovascular Disease

[Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].